Regulatory reforms that improve the competitive landscape for biosimilars will promote drug affordability while incentivizing ...

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic.

Novo Nordisk's NovoCare will now provide uninsured or underinsured patients access to Wegovy for just $499 per month—less ...

Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...

Cost Plus Drugs inked deals with MultiCare Health System, Network Health, Blue Cross and Blue Shield insurers and others ...

NovoCare Pharmacy will provide all dose strengths of Wegovy at a reduced cost of $499 per month for cash-paying patients without insurance.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

For people in San Francisco, access to a neighborhood pharmacy has become much harder in recent years. City leaders are ...

The European orphan drug market is growing and is already comparable in size and scope to the US market. The European Union ...

Novo Nordisk A/S is following in rival Eli Lilly & Co.’s footsteps by selling its hit weight-loss drug Wegovy directly to US ...

This week’s newsletter was originally going to be about the Trump–JD Vance–President Volodymyr Zelensky clash in the Oval ...

It has been 10 years since the first biosimilar was approved by the FDA. The grades on how the market for biosimilars has ...